Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, TRI, IMA

Gwangju Institute of Science and Technology Scientists Shine Light to Measure Blood Flow in the Brain in Real Time


GWANGJU, South Korea, Oct. 21, 2021 /PRNewswire/ -- Cerebral blood flow (CBF), which supplies oxygen and nutrients to our brain, is a crucial indicator of brain health. Information from CBF can, therefore, help us diagnose brain disorders. While this information is usually obtained from speckle imaging, the technique cannot provide information on both flow speed and direction. Now, scientists from GIST take things to the next level with a new technique that quantitatively estimates CBF in real time at high speeds.

The brain is arguably the most crucial aspect of our existence. Our brain health governs how well we function. In turn, our brain health is determined by the blood supply to our brain via "cerebral blood flow" (CBF), which regulates the supply of oxygen and nutrients and removes metabolic by-products. An imbalance in CBF can lead to brain disorders such as headache, seizures, Alzheimer's disease (AD), and stroke.

Observing local CBF during neural activity could, therefore, help unravel the origins of brain disorders. Speckle imaging, a technique based on the analysis of large number of short exposures, is particularly popular in this regard because it is non-invasive, label-free, simple, and provides high time resolution. However, it cannot provide information on both blood flow direction and speed, making it difficult to analyze and monitor changes in blood flow.

In a recent study, researchers led by Prof. Euiheon Chung from the Gwangju Institute of Science and Technology (GIST) in Korea came up with an innovative solution to this problem. The team developed a technique called "optical speckle image velocimetry" (OSIV) that creates an absolute flow map in real time with information on both speed and direction and a superior time resolution. Prof. Chung explains, "We intended to create a new technique that, unlike its predecessors, allows for a quantitative analysis of CBF and does not require complex mathematical modeling for flow measurements." This paper was made available online on 13 August 2021 and was published in Volume 8, Issue 8 of the journal Optica.

OSIV utilizes particle image velocimetry and speckle cross-correlations to detect blood flow velocities up to 7 mm/s and can measure flow maps at up to 190 Hz. To put OSIV to the test, the team used it to image blood flow during a stroke in a mouse brain in vivo, obtaining quantitative flow measurements without needing a tracer or a high-speed camera.

The technique can be successfully deployed to diagnose healthy and diseased brains. "Our study can be used to understand the vascular mechanisms and test new drugs for treating vascular-related diseases such as stroke, AD, and diabetes," speculates Prof. Chung, excitedly.

We certainly hope this is soon realized!

Reference

Title of original paper: Quantitative blood flow estimation in vivo by optical speckle image velocimetry
Journal: Optica
DOI: https://doi.org/10.1364/OPTICA.422871

About the Gwangju Institute of Science and Technology (GIST)

Website: http://www.gist.ac.kr/

Media Contact
Seulhye Kim
[email protected] 
+82 62 715 6253

SOURCE Gwangju Institute of Science and Technology


These press releases may also interest you

at 03:14
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...

10 mai 2024
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

10 mai 2024
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

10 mai 2024
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

10 mai 2024
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

10 mai 2024
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...



News published on and distributed by: